These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7796267)

  • 1. Refined solution structure of the oligomerization domain of the tumour suppressor p53.
    Clore GM; Ernst J; Clubb R; Omichinski JG; Kennedy WM; Sakaguchi K; Appella E; Gronenborn AM
    Nat Struct Biol; 1995 Apr; 2(4):321-33. PubMed ID: 7796267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interhelical angles in the solution structure of the oligomerization domain of p53: correction.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1995 Mar; 267(5203):1515-6. PubMed ID: 7878474
    [No Abstract]   [Full Text] [Related]  

  • 3. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
    Clore GM; Omichinski JG; Sakaguchi K; Zambrano N; Sakamoto H; Appella E; Gronenborn AM
    Science; 1994 Jul; 265(5170):386-91. PubMed ID: 8023159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
    Jeffrey PD; Gorina S; Pavletich NP
    Science; 1995 Mar; 267(5203):1498-502. PubMed ID: 7878469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutually compensatory mutations during evolution of the tetramerization domain of tumor suppressor p53 lead to impaired hetero-oligomerization.
    Mateu MG; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3595-9. PubMed ID: 10097082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the tetrameric minimum transforming domain of p53.
    Lee W; Harvey TS; Yin Y; Yau P; Litchfield D; Arrowsmith CH
    Nat Struct Biol; 1994 Dec; 1(12):877-90. PubMed ID: 7773777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tetramerization in p53 function.
    Chène P
    Oncogene; 2001 May; 20(21):2611-7. PubMed ID: 11420672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.
    McCoy M; Stavridi ES; Waterman JL; Wieczorek AM; Opella SJ; Halazonetis TD
    EMBO J; 1997 Oct; 16(20):6230-6. PubMed ID: 9321402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.
    Noolandi J; Davison TS; Volkel AR; Nie X; Kay C; Arrowsmith CH
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9955-60. PubMed ID: 10944184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oligomerization domain of p53: crystal structure of the trigonal form.
    Miller M; Lubkowski J; Rao JK; Danishefsky AT; Omichinski JG; Sakaguchi K; Sakamoto H; Appella E; Gronenborn AM; Clore GM
    FEBS Lett; 1996 Dec; 399(1-2):166-70. PubMed ID: 8980144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure.
    Blanco FJ; Ortiz AR; Serrano L
    J Biomol NMR; 1997 Jun; 9(4):347-57. PubMed ID: 9255941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution structure of the Tyr41-->His mutant of the single-stranded DNA binding protein encoded by gene V of the filamentous bacteriophage M13.
    Folkers PJ; Nilges M; Folmer RH; Konings RN; Hilbers CW
    J Mol Biol; 1994 Feb; 236(1):229-46. PubMed ID: 8107108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and structure solution of p53 (residues 326-356) by molecular replacement using an NMR model as template.
    Mittl PR; Chène P; Grütter MG
    Acta Crystallogr D Biol Crystallogr; 1998 Jan; 54(Pt 1):86-9. PubMed ID: 9761820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of melanoma growth stimulating activity.
    Fairbrother WJ; Reilly D; Colby TJ; Hesselgesser J; Horuk R
    J Mol Biol; 1994 Sep; 242(3):252-70. PubMed ID: 8089846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR solution structure of a synthetic troponin C heterodimeric domain.
    Shaw GS; Sykes BD
    Biochemistry; 1996 Jun; 35(23):7429-38. PubMed ID: 8652520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.
    Powers R; Garrett DS; March CJ; Frieden EA; Gronenborn AM; Clore GM
    Biochemistry; 1993 Jul; 32(26):6744-62. PubMed ID: 8329398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined solution structure of the glucocorticoid receptor DNA-binding domain.
    Baumann H; Paulsen K; Kovács H; Berglund H; Wright AP; Gustafsson JA; Härd T
    Biochemistry; 1993 Dec; 32(49):13463-71. PubMed ID: 8257681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of murine macrophage inflammatory protein-2.
    Shao W; Jerva LF; West J; Lolis E; Schweitzer BI
    Biochemistry; 1998 Jun; 37(23):8303-13. PubMed ID: 9622482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assignment of 1H(N), 15N, 13C(alpha), 13CO and 13C(beta) resonances in a 67 kDa p53 dimer using 4D-TROSY NMR spectroscopy.
    Mulder FA; Ayed A; Yang D; Arrowsmith CH; Kay LE
    J Biomol NMR; 2000 Oct; 18(2):173-6. PubMed ID: 11101222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ironing out the angles in p53.
    Nat Struct Biol; 1995 Apr; 2(4):253-4. PubMed ID: 7796256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.